Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | I3Tex Ab |
| Country | Sweden |
| Start Date | Aug 02, 2021 |
| End Date | Nov 15, 2024 |
| Duration | 1,201 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2021-03297_Vinnova |
Purpose and goal: CEREBRI aims to further develop and validate a cost-effective biofeedback treatment for patients suffering from migraines. It’s a remote medical device that enables virtual care and home-treatment, using a smartphone and biosensors, that will prevent migraine attacks by 50%, and help patients manage their condition with
self-assessments. We will complete software and hardware optimisation, prototype assembly for a clinical validation study, market assessment and pre-commercialisation planning. Expected results and effects: Prevent migraine attacs by 50% and hel patient manage their condition with self-assessment. Approach and implementation:
** Denna text är maskinöversatt ** Further development of Fingerclip sensor for pulse, pulse variability and temperature Development of electromyography sensor Development of charging station General: development of communication with Bluetooth to smart phone Manufacture of 200 systems for Clinical trials000XCRX000 standard
I3Tex Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant